What is Nutriband Inc Annual Revenue?

Nutriband Inc Annual Revenue fell 0.14%, in the last year to $2.09 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

What is Nutriband Inc Annual Net Profit?

Nutriband Inc Annual Net Profit fell 3.82% in the last year to $5.49 M. Its sector's average net profit growth for the last fiscal year was 4.42%.

What is Nutriband Inc Price to Earning Ratio?

Nutriband Inc Price to Earning Ratio is -8.11, which is negative.

What is Nutriband Inc Stock Price?

Nutriband Inc Stock Price rose 9.41% and outperformed its sector by 12.2% in the past year.

What is Nutriband Inc Quarterly Revenue?

Nutriband Inc Quarterly Revenue rose 50.94% YoY to $0.65 M. Its sector's average revenue growth YoY for the quarter was 8.49%.

What is Nutriband Inc Quarterly Net profit?

Nutriband Inc Quarterly Net profit rose 22.58% YoY to $1.36 M. Its sector's average net profit growth YoY for the quarter was 29.68%.

What is Nutriband Inc Debt to Equity Ratio?

Nutriband Inc Debt to Equity Ratio of 0.04 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Nutriband Inc Return on Equity(ROE)?

Nutriband Inc Return on Equity(ROE) for the last financial year was -73.08%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Nutriband Inc Mutual Fund Holding?

Nutriband Inc Mutual Fund Holding increased by 0.61% in the last quarter to 3.66.

What is Nutriband Inc Interest Coverage Ratio?

Nutriband Inc Interest Coverage Ratio is -71.35, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Nutriband Inc Institutional Holding?

Nutriband Inc Institutional Holding remained the same in the last quarter at 2.21%.

How is the Nutriband Inc today?

The Nutriband Inc today is trading in the down by -1.77% at 5.00.

How has Nutriband Inc performed historically?

The Nutriband Inc is currently trading down -1.77% on an intraday basis in the past week the index fell -18.43%. The index has been up 12.36% in the past quarter and rose 9.41% in the past year. You can view this in the overview section.

Nutriband Inc XNAS: NTRB

Nutriband Inc Live Share Price Today, Share Analysis and Chart

Name: Nutriband Inc: Is Infosys Ltd. worth buying?
Item: Nutriband Inc
Rating: 1.06016675
Author: Trendlyne DVM scores

Download real time

5.00 -0.09 (-1.77%)

57.56% Fall from 52W High

13,699 XNAS Volume

XNAS 08 Apr, 2025 5:30 PM (EDT)

Nutriband Inc Key Metrics

My Metrics

Select

Market Capitalization Below industry Median Unavailable in chosen country	55.5
PE TTM Negative PE TTM Unavailable in chosen country	-8.1
PEG TTM Below industry Median Unavailable in chosen country	0.3
Price to Book Below industry Median Unavailable in chosen country	4.9
Institutional holding current Qtr % Low in industry Unavailable in chosen country	2.2
Revenue Growth Qtr YoY % High in industry Unavailable in chosen country	50.9
Operating Revenue growth TTM % Negative Operating Revenue growth TTM % Unavailable in chosen country	-3.2
Net Profit Qtr Growth YoY % Below industry Median Unavailable in chosen country	22.6
Net Profit TTM Growth % Negative Net Profit TTM Growth % Unavailable in chosen country	-29.6
Operating Profit Margin Qtr % Negative Operating Profit Margin Qtr % Unavailable in chosen country	-220.9
Operating Profit Margin TTM % Negative Operating Profit Margin TTM % Unavailable in chosen country	-298.4
Piotroski Score Below industry Median Unavailable in chosen country	2
Rel Perf vs Sector quarter% Unavailable in chosen country	21.7
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-73.1
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-64.6

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

5.2 / 100

Technically Neutral

37.2 / 100

1Yr Price target upside is 160%

1 analysts

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

Nutriband Inc Stock Price Analysis

Day Price Range -1.8% 1 Day return Unavailable in chosen country	5 (LTP) 55.4 LowHigh
Week Price Range -18.4% 1 Week return Unavailable in chosen country	5 (LTP) 4.56.2 LowHigh
Month Price Range -23.2% 1 Month return Unavailable in chosen country	5 (LTP) 4.56.9 LowHigh
52 Week Price Range 9.4% 1 Year return Unavailable in chosen country	5 (LTP) 3.211.8 LowHigh

View full Share Price History

Nutriband Inc Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Inline

Nutriband Inc's Revenue was higher than average estimate 1 time in past 2 years

EPS forecast

QUARTER
ANNUAL

Current EPS

-0.6

Avg. Estimate

-0.6

Low Estimate

-0.6

High Estimate

-0.6

Current EPS

Avg. Estimate

Consensus Recommendation

1 ANALYST Recommendations

STRONG BUY

The consensus recommendation from 1 analyst for Nutriband Inc is STRONG BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Nutriband Inc Stock Analysis

Nutriband Inc stock analysis with key metrics, changes, and trends.

Nutriband Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$2.09 M	0.14%	negative	Annual Revenue fell 0.14%, in the last year to $2.09 M. Its sector's average revenue growth for the last fiscal year was 8.57%.
Annual Net Profit	$5.49 M	3.82%	negative	Annual Net Profit fell 3.82% in the last year to $5.49 M. Its sector's average net profit growth for the last fiscal year was 4.42%.
Price to Earning Ratio	-8.11	-	negative	Price to Earning Ratio is -8.11, which is negative.
Stock Price	$5.00	9.41%	positive	Stock Price rose 9.41% and outperformed its sector by 12.2% in the past year.
Quarterly Revenue	$0.65 M	50.94%	positive	Quarterly Revenue rose 50.94% YoY to $0.65 M. Its sector's average revenue growth YoY for the quarter was 8.49%.
Quarterly Net profit	$1.36 M	22.58%	positive	Quarterly Net profit rose 22.58% YoY to $1.36 M. Its sector's average net profit growth YoY for the quarter was 29.68%.
Debt to Equity Ratio	0.04	-	positive	Debt to Equity Ratio of 0.04 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	-73.08 %	-73.08%	negative	Return on Equity(ROE) for the last financial year was -73.08%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	3.66 %	0.61%	positive	Mutual Fund Holding increased by 0.61% in the last quarter to 3.66.
Interest Coverage Ratio	-71.35	-	negative	Interest Coverage Ratio is -71.35, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).
Institutional Holding	2.21 %	0%	neutral	Institutional Holding remained the same in the last quarter at 2.21%.

VIEW LESS

Loading data..

Nutriband Inc - Company Profile

What does Nutriband Inc do?

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Year

Dr. Jeff Patrick, Pharm.D.

Chief Scientific Officer

2024

Gross Remuneration

Year

Nutriband Inc Board of directors

All Gross Remunerations are in USD

Mr. Sergei Glinka

Director

2025

Gross Remuneration

Year

Nutriband Inc Live Share Price Today, Share Analysis and Chart

57.56% Fall from 52W High

Nutriband Inc Key Metrics

Market Capitalization

PE TTM

PEG TTM

Rel Perf vs Sector quarter%

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

ROE Annual %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

RoA Annual %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Nutriband Inc Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Nutriband Inc Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Nutriband Inc's Revenue was higher than average estimate 1 time in past 2 years

EPS forecast

Consensus Recommendation

The consensus recommendation from 1 analyst for Nutriband Inc is STRONG BUY

Nutriband Inc Stock Analysis

Nutriband Inc stock analysis with key metrics, changes, and trends.

Annual Revenue fell 0.14%, in the last year to $2.09 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit fell 3.82% in the last year to $5.49 M. Its sector's average net profit growth for the last fiscal year was 4.42%.

Price to Earning Ratio is -8.11, which is negative.

Stock Price rose 9.41% and outperformed its sector by 12.2% in the past year.

Quarterly Revenue rose 50.94% YoY to $0.65 M. Its sector's average revenue growth YoY for the quarter was 8.49%.

Quarterly Net profit rose 22.58% YoY to $1.36 M. Its sector's average net profit growth YoY for the quarter was 29.68%.

Debt to Equity Ratio of 0.04 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was -73.08%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding increased by 0.61% in the last quarter to 3.66.

Interest Coverage Ratio is -71.35, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding remained the same in the last quarter at 2.21%.

Nutriband Inc - Company Profile

What does Nutriband Inc do?

Nutriband Inc Management structure

Mr. Serguei Melnik

Chairman of the Board, President and Secretary

Mr. Gareth Sheridan

Chief Executive Officer and Director

Dr. Alan Smith, PhD

Chief Operating Officer and President of 4P Therapeutics

Mr. Gerald Goodman

Chief Financial Officer and Principal Accounting officer

Mr. Patrick Ryan, PhD

Chief Technical Officer

Dr. Jeff Patrick, Pharm.D.

Chief Scientific Officer

Nutriband Inc Board of directors

Mr. Sergei Glinka

Director

Nutriband Inc FAQ